To continue reading this content, please enable JavaScript in your browser settings and refresh this page. You have a great idea for an invention, and you think it is ...
VisionWave Holdings, Inc. (NASDAQ: VWAV) (the “Company” or “VisionWave”) today announced the filing of a U.S. provisional patent application covering SkyWeave™, an intelligent high-frequency ...
NEW YORK, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Raphael Pharmaceutical Inc. (“Raphael Pharmaceutical” or the “Company”) (OTCQB: RAPH), a clinical-stage biotechnology company developing an innovative ...
Provisional patent applications are popular in the U.S. for the various advantages they may provide applicants, including lower filing costs, less restrictive United States Patent and Trademark Office ...
As part of the effort to harmonize global patent systems, the United States introduced the provisional patent application in 1995 as part of the GATT Uruguay Round agreement. As part of the effort to ...
VisionWave Holdings, Inc. (NASDAQ: VWAV) (the “Company” or “VisionWave”) today announced the filing of a provisional patent application number 64/111,834 with the United States Patent and Trademark ...
Vector Science & Therapeutics Corp. (TSXV: PAIN) today announced the filing of a provisional patent application covering a wearable transdermal delivery platform that uses a pulsed magnetic field to ...
NESS ZIONA, Israel, Sept. 1, 2021 /PRNewswire/ -- MeaTech 3D Ltd. (Nasdaq: MITC), a technology company developing a suite of advanced manufacturing technologies to produce more environmentally ...
WEST PALM BEACH, Florida, May 27, 2026 (GLOBE NEWSWIRE) -- Quantum Cyber N.V. (Nasdaq: QUCY) (“Quantum Cyber” or the “Company”), a Nasdaq-listed autonomous defense technology company assembling an ...
Key HighlightsProvisional U.S. patent application has been filed for MASQ™ (Machine Action Security Quotient), an infrastructure-layer technology designed to govern and secure autonomous AI agent ...
QUEBEC CITY--(BUSINESS WIRE)--Devonian Health Group Inc. (“Devonian” or the “Company”) (TSXV: GSD; OTCQB: DVHGF), a clinical stage corporation focused on developing unique solutions to inflammatory ...